225
Participants
Start Date
September 30, 2001
Primary Completion Date
November 30, 2001
Study Completion Date
November 30, 2001
Intranasal Placebo
Intranasal placebo
Intranasal Morphine 15 mg
Intranasal Morphine 15 mg
Immediate Release Oral Morphine 60 mg
Immediate Release Oral Morphine 60 mg
Intravenous morphine
Intravenous morphine 7.5 mg
Intranasal morphine 7.5 mg
Intranasal morphine 7.5 mg
Oral placebo
Oral placebo
Intravenous placebo
Intravenous placebo
Lead Sponsor
Javelin Pharmaceuticals
INDUSTRY